Phytate (inositol hexaphosphate; InsP 6 ) was determined in rat tissues fed on diets with different phytate contents, using a GC -mass detection methodology that permitted the evaluation of the total amount of this substance present in such tissues. The highest InsP 6 concentrations were found in brain ð5 : 89 Â 10 22 (SE 5 : 7 Â 10 23 Þ mg/g DM), whereas the concentrations detected in kidneys, liver and bone were similar to each other ð1 : 96 Â 10 23 (SE 0 : 20 Â 10 23 Þ; 3 : 11 Â 10 23 (SE 0 : 24 Â 10 23 Þ; 1 : 77 Â 10 23 (SE 0 : 17 Â 10 23 Þ mg/g DM respectively) and 10-fold less than those detected in brain. When rats were fed on a purified diet in which InsP 6 was undetectable, the InsP 6 levels of the organs mentioned earlier decreased dramatically ð9 : 0 Â 10 24 ; 3 : 8 Â 10 25
Phytate (inositol hexaphosphate; InsP 6 ) was determined in rat tissues fed on diets with different phytate contents, using a GC -mass detection methodology that permitted the evaluation of the total amount of this substance present in such tissues. The highest InsP 6 concentrations were found in brain ð5 : 89 Â 10 22 (SE 5 : 7 Â 10 23 Þ mg/g DM), whereas the concentrations detected in kidneys, liver and bone were similar to each other ð1 : 96 Â 10 23 (SE 0 : 20 Â 10 23 Þ; 3 : 11 Â 10 23 (SE 0 : 24 Â 10 23 Þ; 1 : 77 Â 10 23 (SE 0 : 17 Â 10 23 Þ mg/g DM respectively) and 10-fold less than those detected in brain. When rats were fed on a purified diet in which InsP 6 was undetectable, the InsP 6 levels of the organs mentioned earlier decreased dramatically ð9 : 0 Â 10 24 ; 3 : 8 Â 10 25 ; 1 : 4 Â 10 25 mg/g DM in brain, kidneys and liver respectively) and in some cases became undetectable (bone). The addition of InsP 6 to this purified diet led to the increase of InsP 6 levels in these tissues. This clearly demonstrated that the majority of the InsP 6 found in organs and tissues has a dietary origin and is not a consequence of endogenous synthesis. Consequently, considering that InsP 6 could be involved in some important biological roles, the value of any diet on supplying this substance is noteworthy.
Phytate: Bone: Calcium: Zinc Phytate (inositol hexaphosphate; InsP 6 ) has been found in cells at total amounts about 10-100 mM Szwergold et al. 1987; Pittet et al. 1989; French et al. 1991; Bunce et al. 1993) . A part of InsP 6 may be bound to membranes and to proteins and it is not really clear how much is freely soluble. It is important to note that these concentrations have been found using cultures of different cell types treated by [ 3 H]inositol in the medium, and the cellular radioactive InsP 6 formed was determined radiometrically after separation by HPLC. The problem in these experiments is that the InsP 6 pool incorporates radioactive inositol so slowly that it may take more than 1 week to reach the equilibrium, and it is possible that radioactivity is responsible for cell stimulation. In fact the InsP 6 synthesis has been studied in model systems outside the animal kingdom: in Dictyostelium (Stephens & Irvine, 1990) , in yeast (Ongusaha et al. 1998; York et al. 1999) and in Spirodela polyrhiza (Brearly & Hanke, 1996) . In all cases Ins(1,3,4,5,6)P 5 was identified as the immediate precursor of the InsP 6 . Nevertheless, the controversy about the InsP 6 synthesis in animal cells continues and the pathways of de novo InsP 6 formation in such cases are not established (Sasakawa, 1995) . On the other hand, InsP 6 is widespread in the vegetal kingdom, mainly in seeds, and as a consequence, has been an important dietary component of animals and man from ancient ages.
InsP 6 may be involved in the control of several intra-and extracellular physiological processes. Thus, diverse groups have suggested that InsP 6 might participate in the intracellular regulations of surface receptions channels (O'Rourke et al. 1996; Efanov et al. 1997; Larsson et al. 1997) . Moreover, a number of actions, such as extracellular mediator of InsP 6 , were pointed out (Vallejo et al. 1987; Luttrel, 1993) . In addition, antioxidant properties have been described (Hawkins, 1993) and a potent activity for preventing pathological calcifications was also demonstrated Conte et al. 1999; Grases et al. 2000a,b) .
All these aspects commented on seem to indicate an important biological role of InsP 6 , but a number of unclear facts need further study and clarification (Menniti et al. 1993; Irvine, 1995) . Thus, as has been pointed out earlier, the majority of data related to InsP 6 cell content has been evaluated through cell cultures and radioactive measurements after long-term culture with radioactive inositol. Undoubtedly, an important missing clue to the possible importance and functions of InsP 6 is the determination of its real levels in different mammalian tissues. In the present study, InsP 6 was determined in rat tissues fed on diets with different InsP 6 contents, using a GC -mass detection methodology that permitted the evaluation of the total amount of this substance present in such tissues.
Material and methods

Animals and diets
Female Wistar rats (21-d-old) from Harlan Ibérica S.A. (Barcelona, Spain) were acclimated to our animal house for 7 d and kept on diet and tap water ad libitum. The rats were housed two animals per cage at a temperature of 23^18C and relative humidity of 50 % with a 12 h light -dark cycle. The animals were assigned randomly to three groups of twelve rats each.
The diets used were AIN-76A (Harland Tekland, Madison, WI, USA), a purified diet in which InsP 6 is undetectable, an AIN-76A diet to which phytate dodecasodium salt from corn (Sigma-Aldrich, Madrid, Spain) was added (AIN-76A+10 g InsP 6 /kg) and the standard nonpurified diet pellets (UAR A03; Panlab s.1., Barcelona, Spain). Each experimental group (AIN-76A, AIN-76A+10 g InsP 6 /kg and standard non-purified diet) was fed on one of the different diets for 12 weeks. Representative compositions of AIN-76A, AIN-76A+10 g InsP 6 /kg and standard non-purified diets are shown in Table 1 .
On the final day of the experiment, urine was collected for 24 h by housing the rats of the respective groups in different metabolic cages (Tecniplast Gazzada s.a.r.l.; Buguggiate, Italy) and the next day all animals were anaesthetised with pentobarbital (50 mg/kg, intraperitoneal), killed, and kidneys, liver, brain, bone (femur) and blood were removed.
The procedures used in this experiment were made according to the Directive 86/609/EEC regarding the protection of animals used for experimental and other scientific purposes.
Reagents
All chemicals were of analytical reagent grade. Granular activated C (100 mesh) and Na 2 EDTA were purchased from Panreac (Barcelona, Spain), the anion exchange resin was AG 1-X8 (200 -400 mesh) from Bio-Rad (Hercules, CA, USA), and InsP 6 (from corn), scyllo-inositol, myo-inositol, pyridine (anhydrous), hexane, methanol, chloroform and TCA were from Sigma (Madrid, Spain).
Derivation chemicals, 1,1,1,3,3,3-hexamethyldisilazane and chlorotrimethylsilane, were purchased from Aldrich (Steinheim, Germany). Crude phytase from Aspergillus ficcum, 3 : 5 units specific activity/mg was from Sigma. A suspension containing 1 : 0 mg crude phytase/ml was prepared in 3 Â 10 23 M-HCl solution with magnetic stirring.
Sample treatment for mineral determination
Treatment of kidney, liver, brain and plasma. The kidney, liver, brain and plasma were lyophilised (Cryodos; Telstar, Barcelona, Spain) to constant weight and ashed in a muffle furnace at 5008C for 24 h until white ash was attained. The ash was dissolved in 1 M-HCl and the concentrations of Ca, Mg, P and Zn were determined by inductively-coupled plasma atomic emission spectrometry. Treatment of bone. The bone samples were pulverised to a uniform blend and were dissolved with 12 M-HCl. A portion of this solution was diluted for convenience to carry out the analysis of mineral content.
Treatment of urine. A portion of urine was diluted to convenience with 1 M-HCl. This solution was used to carry out the analysis of mineral content.
Sample treatment for phytate determination
Treatment for kidney, liver and brain. Tissues were rapidly frozen at 2208C to reduce any metabolic activity. For analysis it was lyophilised and pulverised to a uniform blend. The lipids were removed according to Folch's method (Folch et al. 1957 ). An appropriate amount of sample was twice treated with 3 ml chloroform -methanol (2:1, v/v). The liquid phase was discarded and the solid phase was homogenised in 5 ml water using an Ultra-Turrax homogeniser (Staufen, Germany) (20 s at 13 500 rpm, three times). 0 : 1 ml 0 : 1 M-Na 2 EDTA for each 20 mg tissue were added, and the mixture stirred for 1 h. 0 : 2 ml 1 M-TCA (for each 20 mg tissue) were added to denaturise protein. The solid phase was separated by centrifugation at 3500 rpm for 5 min. The supernatant was quantitatively transferred to a vial, and neutralised with NaOH to pH 3 -4. Using this solution, the procedure described later for InsP 6 determination was followed.
Treatment of plasma. Whole blood in 6 Iu heparin/ml was centrifuged at 3500 rpm for 15 min. Portions of the supernatant fraction were treated with 0 : 1 ml 0 : 1 M-Na 2-EDTA and 0 : 2 ml 1 M-TCA/ml plasma. Using this solution, the procedure described later for InsP 6 determination was followed.
Treatment of bone. The sample, pulverised to a uniform blend, was shaken with 0 : 2 ml 12 M-HCl for 3 h. The suspension was then diluted to pH 3 -4 and filtered through a 0 : 45 mm filter. The method continued as in the procedure described later.
Treatment of urine. Urine was acidified with HCl to pH 3 -4. The sample was purified using a chromatographic column with 0 : 5 g activated C, and analysed as in the procedure described later.
Separation of phytic acid from lower inositol ester, myo-inositol and scyllo-inositol
The separation of phytic acid from InsP 5 , InsP 4 , InsP 3 free myo-inositol and scyllo-inositol was carried out using a strong anionic exchange resin (AG 1-X8, 200-400 mesh; Bio-Rad). It is known that phytic acid is strongly retained on such resin at pH .1 : 5 (March et al. 1998) . However, inositols are not retained and 5 ml 3 Â 10 23 M-HCl was sufficient for complete elution of lower inositol ester and inositols. These results were supported by several recovery experiments carried out with four different matrices: standards, artificial urine, human urine and rat kidney (March et al. 2000) .
Hydrolysis of phytic acid
The hydrolysis of phytic acid to inositol can be accomplished by heating it in acid media for a long time (March et al. 1998) or enzymically (March et al. 1995) . The results obtained from the study of the enzymic hydrolysis led to the following conclusions: (1) no interaction of free inositol with the enzyme was detected; (2) the yield of the hydrolysis reached a maximum for a 0 : 5 h incubation time; (3) phytic acid was quantitatively transformed to myoinositol.
Phytate determination
InsP 6 in organs, plasma and urine was determined essentially according to March et al. (2000) . A chromatographic column ð16 Â 5 mmÞ containing 0 : 2 g anionic resin was equilibrated with 3 Â 10 23 M-HCl. Solutions of phytic acid at pH 3 -4, containing from 0 : 004 to 0 : 100 mg (as phytic acid) were passed through the column, where phytic acid was retained. The column was washed with 7 ml 3 Â 10 23 M-HCl. Then, 0 : 5 ml 3 Â 10 23 M-HCl and 0 : 1 ml phytase enzyme suspension were added, and the column was closed. Its content was mixed by rotation at 1 rpm for 1 h at 378C. The liquid phase was transferred to a vial and the column washed with 2 ml 0 : 05 M-HCl. Scyllo-inositol, (0 : 01mg in aqueous solution) was added to the vial (internal standard). Then it was frozen at 2208C and lyophilised. The residue was reconstituted by 1 ml pyridine and 0 : 2 ml hexamethyldisilazane and 0 : 7 ml chlorotrimethylsilane were added. The solution was maintained at 1008C for 1 h. After reaction, the excess of reagents and organic solvent were blown off in a stream of N 2 . The solid residue was extracted with 2 ml hexane. The solution obtained was evaporated and the residue reconstituted in 200 ml hexane. Of this solution, 1 ml was injected into a GC -MS (Shimadzu QP-5000 gas chromatograph (Kyoto, Japan) using fused silica capillary column SPB-20 (Supelco, Bellefonte, PA, USA) and He as carrier gas). The calibration graph was obtained from peak height corresponding to the silylated compounds of scyllo-and myo-inositol, at 13 : 8 and 14 : 5 min respectively.
The detection limit of the method was 9 mg phytic acid/l. The CV of analysed real samples ranged from 2 : 1 to 2 : 8 %. Biological samples contain significant amounts of myoinositol phosphate as well as a number of myo-inositol polyphosphates (Bunce et al. 1993) . Then, the interference from lower esters than InsP 6 was studied. Working with standards containing 0 : 125 mg InsP 6 it was found that 0 : 5 mg Ins(1,4,5)P 3 and Ins(1,3,4,6)P 4 did not cause any significant error. Nevertheless, in the same conditions, Ins(1,3,4,5,6)P 5 caused a positive interference (+15 %). The maximum amount of Ins(1,3,4,5,6)P 5 tolerated when determining 0 : 125 mg InsP 6 was 0 : 125 mg. Considering that the amount of phytic acid retained in the column containing anionic resin, when analysing biological samples, oscillates between 0 : 004 and 0 : 100 mg InsP 6 , and the lower esters in such samples are present at lower concentrations than InsP 6 (the amount of InsP 5 in kidney is half of the amount of InsP 6 and in brain and bone is a third of InsP 6 ; F Grases, BM Simonet, RM Prieto and JG March, unpublished results), it was concluded that the present method can be considered specific for InsP 6 .
Statistics
Values in the tables and figures are expressed as mean values with their standard errors. One-way ANOVA was used to calculate significance of differences between groups. The Student t test was used to assess differences of means. The SPSS for the Windows program (SPSS, Chicago, IL, USA) was used for statistical computations. A probability of P , 0 : 05 was used for assessing statistical significance.
Results
The amounts of InsP 6 found in blood, urine, kidneys, liver, brain and bone of rats treated with three different diets were determined and are shown in Fig. 1 . The mineral status of these tissues was also established and appears in Table 2 . As can be deduced from these results, the highest InsP 6 concentrations were found in brain, whereas the amounts detected in kidneys, liver and bone were similar to each other and 10-fold less than those detected in brain. When rats were fed with AIN-76A diet, a purified diet in which InsP 6 is practically absent, the InsP 6 levels of the mentioned organs decreased dramatically and in some cases, as in bone, became undetectable. Nevertheless, the addition of InsP 6 to the AIN-76A purified diet led to the increase of the InsP 6 levels in the tissues mentioned earlier. It is important to observe that no significant differences between the mineral status of the studied tissues, except Ca in the kidney, as a consequence of the treatment with the three different contents of InsP 6 in the diets, were observed. Rats fed the AIN-76A diet had high Ca concentrations in their kidneys when compared with standard diet-fed rats, whereas the concentration was significantly reduced in rats fed with the AIN-76A+10 g InsP 6 /kg.
Discussion
As can be deduced from the present results InsP 6 is widely distributed among animal tissues, the brain being the organ with the highest concentration found and the blood with the Table 1 and p. 226. Mean values were significantly different from those of the UAR-A03 standard diet group (student t test): * P , 0 : 05: Mean values were significantly different from those of the AIN-76A+10 g phytate/kg diet group: † P , 0 : 05: lowest. It is very important to observe that on removing InsP 6 from diet (AIN-76A diet) and after 12 weeks, the InsP 6 levels decreased to very low or even undetectable values in all the studied organs and tissues. Nevertheless, the addition of InsP 6 to the diet AIN-76A increased the InsP 6 levels of the studied tissues, including brain, in spite of the difficulties of crossing the blood -brain barrier. This clearly demonstrated that the majority of the InsP 6 found in organs and tissues has a dietary origin and is not a consequence of endogenous synthesis. Previous studies using rats demonstrated the relationship between the oral administration of InsP 6 and its excretion in the urine, so the urinary level declines when InsP 6 is withheld and increases with a greater amount of ingested InsP 6 , reaching a peak excretion level which is not further increased by ingestion of additional quantities of InsP 6 . The minimum amount that gives maximum absorption corresponds to low InsP 6 ingestion (Grases et al. 2000c) . Thus, given the mean weight of 279 g/rat an ingested amount of 20 : 9 mg body weight InsP 6 /kg gave the maximum absorption. Considering the InsP 6 content of the standard diet (analysed value 9 g/kg diet) it is clear that it is enough to provide maximum InsP 6 absorption. Obviously, the diet AIN-76A+10 g InsP 6 / kg diet (analysed value 11 : 6 g/kg) also has a sufficient InsP 6 content to give maximum absorption. Nevertheless, as can be seen in Fig. 1 , the InsP 6 content of the majority of the tissues was lower in animals fed the AIN-76A+10 g InsP 6 /kg when compared with standard diet-fed animals, in spite of excreting similar amounts and presenting similar plasma values. Therefore, such differences in tissue contents must be a consequence of the different diet composition. Considering that InsP 6 could be implied in some important biological roles, as is pointed out on p. 225, the value of any diet in supplying this substance is clear. In fact, as it was demonstrated in a previous paper (Grases et al. 2000b) , the absence of InsP 6 in the AIN-76A diet provoked the development of pathological calcifications in the kidneys of female rats that were prevented with InsP 6 addition to diet. The development of calcifications was also accompanied by anomalous Ca accumulation in the rat kidneys, whereas this amount was significantly reduced in female rats fed on the AIN-76A+10 g InsP 6 /kg. As would be expected, the same results were observed in the present paper (see Table 2 ). Moreover, low values of urinary InsP 6 were also detected in a group of oxalocalcic stone-formers when compared with the urinary levels observed in healthy subjects (Grases et al. 2000a) . All these results demonstrate the importance of dietary InsP 6 in maintaining adequate levels of this compound in the different organs and tissues.
On the other hand, the tendency at present towards the elimination of InsP 6 from the diet in the developed countries as a consequence of the use of refined cereals, low consumption of legumes and nuts etc. can cause an important deficit of InsP 6 levels in the organism. This is strengthened by the so-called antinutrient properties of InsP 6 . In this respect, as can be seen in Table 2 , the amount of InsP 6 added to the AIN-76A diet did not significantly affect the animals' mineral status. Nevertheless, it is clear that the administration of large amounts of InsP 6 , together with diets of a poor mineral content, can produce deficiencies in mineral element status by a decreased mineral bioavailability, according to the data in the literature (Maga, 1982; Anonymous, 1987; Harland & Oberleas, 1987; Hurrell, 1992; Sandstrom & Sandberg, 1992; Davidsson, 1997; Sandberg, 1999) .
Obviously, the administration of high InsP 6 doses, as in the handling of vitamins, must be adequately controlled and the content of minerals of the corresponding diet must be also considered. In fact, several studies demonstrate that if mineral intakes are adequate and cereal or bran intakes are maintained at moderate levels, there should be no adverse effects on mineral biovailability. Thus, intakes of 2 g InsP 6 and as much as 32 g dietary fibre/d did not generally affect mineral balances when mineral intake was sufficient (Kelsay et al. 1987) .
